This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
Methyltransferase inhibitors to treat myelodysplastic syndromes
Sorafenib for advanced-stage hepatocellular carcinoma
NICE clears sunitinib for GIST
Doing more with less – IT and automation are the way forward
Boehringer Ingelheim becomes founding sponsor of World Stroke Academy
UCB launches Vimpat in the US
Xeloda made fingerprints disappear
Green tea “can fight leukaemia”
Amgen acquires heart-drug rights
Cancer drug causes gut perforations
Sanofi wins US flu-virus contract
Innovative treatment approach offers new hope for eczema sufferers
« Previous
1
…
135
136
137
138
139
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: